OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Anti-drug resistance, anti-inflammation, and anti-proliferation activities mediated by melatonin in doxorubicin-resistant hepatocellular carcinoma: in vitro investigations
Ahmed R. Hamed, Shaymaa M.M. Yahya, Heba K. Nabih
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 6, pp. 1117-1128
Open Access | Times Cited: 11
Ahmed R. Hamed, Shaymaa M.M. Yahya, Heba K. Nabih
Naunyn-Schmiedeberg s Archives of Pharmacology (2023) Vol. 396, Iss. 6, pp. 1117-1128
Open Access | Times Cited: 11
Showing 11 citing articles:
Embolization-on-a-chip: Novel Vascularized Liver Tumor Model for Evaluation of Cellular and Cytokine Response to Embolic Agents
Huu Tuan Nguyen, Zuzana Tirpáková, Arne Peirsman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Huu Tuan Nguyen, Zuzana Tirpáková, Arne Peirsman, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Melatonin mitigated methotrexate-induced hepatotoxicity through interrelated biological processes
Noura A. Abd-Allah, Maggie E. Amer, Maher A. Amer, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Noura A. Abd-Allah, Maggie E. Amer, Maher A. Amer, et al.
Molecular Biology Reports (2024) Vol. 51, Iss. 1
Closed Access | Times Cited: 4
Melatonin modulates tumor metabolism and mitigates metastasis
Russel J. Reıter, Ramaswamy Sharma, Dun‐Xian Tan, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 4, pp. 321-336
Open Access | Times Cited: 10
Russel J. Reıter, Ramaswamy Sharma, Dun‐Xian Tan, et al.
Expert Review of Endocrinology & Metabolism (2023) Vol. 18, Iss. 4, pp. 321-336
Open Access | Times Cited: 10
Restoring microRNA-34a overcomes acquired drug resistance and disease progression in human breast cancer cell lines via suppressing the ABCC1 gene
Shaymaa M.M. Yahya, Heba K. Nabih, Ghada H. Elsayed, et al.
Breast Cancer Research and Treatment (2023) Vol. 204, Iss. 1, pp. 133-149
Open Access | Times Cited: 8
Shaymaa M.M. Yahya, Heba K. Nabih, Ghada H. Elsayed, et al.
Breast Cancer Research and Treatment (2023) Vol. 204, Iss. 1, pp. 133-149
Open Access | Times Cited: 8
Anti-proliferative effect of melatonin in human hepatoma HepG2 cells occurs mainly through cell cycle arrest and inflammation inhibition
Heba K. Nabih, Ahmed R. Hamed, Shaymaa M.M. Yahya
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Heba K. Nabih, Ahmed R. Hamed, Shaymaa M.M. Yahya
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Disulfidptosis and ferroptosis related genes predict prognosis and personalize treatment for hepatocellular carcinoma
Jinfeng Liu, Lei Huang, Xiaoping Zhou, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 496-514
Open Access | Times Cited: 1
Jinfeng Liu, Lei Huang, Xiaoping Zhou, et al.
Translational Cancer Research (2024) Vol. 13, Iss. 2, pp. 496-514
Open Access | Times Cited: 1
MELATONIN ENHANCES TEMOZOLOMIDE-INDUCED APOPTOSIS IN GLIOBLASTOMA AND NEUROBLASTOMA CELLS
Ayten Bostancı, Oğuzhan Doğanlar
Experimental Oncology (2024) Vol. 46, Iss. 2, pp. 87-100
Open Access | Times Cited: 1
Ayten Bostancı, Oğuzhan Doğanlar
Experimental Oncology (2024) Vol. 46, Iss. 2, pp. 87-100
Open Access | Times Cited: 1
Peptidic Compound as DNA Binding Agent: In Silico Fragment-based Design, Machine Learning, Molecular Modeling, Synthesis, and DNA Binding Evaluation
Dara Dastan, Shabnam Soleymanekhtiari, Ahmad Ebadi
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 332-344
Closed Access
Dara Dastan, Shabnam Soleymanekhtiari, Ahmad Ebadi
Protein and Peptide Letters (2024) Vol. 31, Iss. 4, pp. 332-344
Closed Access
Melatonin and Cancer: New Insights
Emma Sola, Eva Ramos, Emilio Gil‐Martín, et al.
Interdisciplinary cancer research (2024)
Closed Access
Emma Sola, Eva Ramos, Emilio Gil‐Martín, et al.
Interdisciplinary cancer research (2024)
Closed Access
Role of ABCC5 in cancer drug resistance and its potential as a therapeutic target
Yu Pan, Mengmeng Wu, Huazhong Cai
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Yu Pan, Mengmeng Wu, Huazhong Cai
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access
Melatonin in cancer research and treatment
Wamidh H. Talib, Safwan Abdel Rahim, Laith M.H. Al-Shdifat, et al.
Elsevier eBooks (2024), pp. 239-257
Closed Access
Wamidh H. Talib, Safwan Abdel Rahim, Laith M.H. Al-Shdifat, et al.
Elsevier eBooks (2024), pp. 239-257
Closed Access
Potential of melatonin to reverse epigenetic aberrations in oral cancer: new findings.
Emilio Gil‐Martín, Eva Ramos, Francisco López‐Muñoz, et al.
PubMed (2023) Vol. 22, pp. 1280-1310
Closed Access
Emilio Gil‐Martín, Eva Ramos, Francisco López‐Muñoz, et al.
PubMed (2023) Vol. 22, pp. 1280-1310
Closed Access
